Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H28O2 |
Molecular Weight | 288.4244 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CC[C@@]4([H])CC(=O)C=C[C@]34C
InChI
InChIKey=OKJCFMUGMSVJBG-ABEVXSGRSA-N
InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h7,9,12,14-17,21H,3-6,8,10-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1
Molecular Formula | C19H28O2 |
Molecular Weight | 288.4244 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. | 2005 Jul |
|
17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties. | 2006 Aug 20 |
|
An efficient synthesis of 5alpha-androst-1-ene-3,17-dione. | 2006 Dec |
|
Presence of endogenous interferences in the urinary detection of selected anabolic steroids by liquid chromatography/electrospray tandem mass spectrometry. | 2007 |
|
Mass spectrometric detection of and similarities between 1-androgens. | 2007 Mar 14 |
|
Detection of anabolic steroids in dietary supplements: the added value of an androgen yeast bioassay in parallel with a liquid chromatography-tandem mass spectrometry screening method. | 2009 Apr 1 |
|
Improved ultrasonic-based sample treatment for the screening of anabolic steroids by gas chromatography/mass spectrometry. | 2010 Aug 30 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 21:50:22 GMT 2023
by
admin
on
Fri Dec 15 21:50:22 GMT 2023
|
Record UNII |
Y984BV1Q0G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-1-Testosterone
Created by
admin on Fri Dec 15 21:50:22 GMT 2023 , Edited by admin on Fri Dec 15 21:50:22 GMT 2023
|
||
|
DEA NO. |
4000
Created by
admin on Fri Dec 15 21:50:22 GMT 2023 , Edited by admin on Fri Dec 15 21:50:22 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
65-06-5
Created by
admin on Fri Dec 15 21:50:22 GMT 2023 , Edited by admin on Fri Dec 15 21:50:22 GMT 2023
|
PRIMARY | |||
|
DB01481
Created by
admin on Fri Dec 15 21:50:22 GMT 2023 , Edited by admin on Fri Dec 15 21:50:22 GMT 2023
|
PRIMARY | |||
|
236666
Created by
admin on Fri Dec 15 21:50:22 GMT 2023 , Edited by admin on Fri Dec 15 21:50:22 GMT 2023
|
PRIMARY | |||
|
1-TESTOSTERONE
Created by
admin on Fri Dec 15 21:50:22 GMT 2023 , Edited by admin on Fri Dec 15 21:50:22 GMT 2023
|
PRIMARY | |||
|
Y984BV1Q0G
Created by
admin on Fri Dec 15 21:50:22 GMT 2023 , Edited by admin on Fri Dec 15 21:50:22 GMT 2023
|
PRIMARY | |||
|
DTXSID80215312
Created by
admin on Fri Dec 15 21:50:22 GMT 2023 , Edited by admin on Fri Dec 15 21:50:22 GMT 2023
|
PRIMARY | |||
|
121140
Created by
admin on Fri Dec 15 21:50:22 GMT 2023 , Edited by admin on Fri Dec 15 21:50:22 GMT 2023
|
PRIMARY | |||
|
59714
Created by
admin on Fri Dec 15 21:50:22 GMT 2023 , Edited by admin on Fri Dec 15 21:50:22 GMT 2023
|
PRIMARY | |||
|
C520094
Created by
admin on Fri Dec 15 21:50:22 GMT 2023 , Edited by admin on Fri Dec 15 21:50:22 GMT 2023
|
PRIMARY | |||
|
39366
Created by
admin on Fri Dec 15 21:50:22 GMT 2023 , Edited by admin on Fri Dec 15 21:50:22 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |